Skip to main content
. 2021 Jan 7;22:13. doi: 10.1186/s12882-020-02217-6

Table 2.

Clinical and biochemical characteristics of PD patients in this study (n = 93)

Variable Group1※
≤5 (n=38)
Group2※
>5 (n=55)
t/χ2 P value
Age (year) 63.0±13.1 59.1±13.4 1.397 0.166
Diabetes (n, %) 15 (39.5) 23 (41.8) 0.180 0.671
Male (n, %) 20 (52.6) 31 (56.4) 0.126 0.722
Atherosclerosis (n, %) 23 (60.5) 20 (36.4) 3.699 0.054
Peritonitis (n, %) 8 (21.1) 9 (16.4) 0.331 0.565
Dialysis duration (months) 36.4±26.5 28.4±22.6 1.576 0.118
Number of Hospitalizations 11.56±7.7 7.8±4.7 2.701 0.009
BMI (kg/m2) 21.7±3.1 23.5±2.7 −2.899 0.006
Serum albumin (g/L) 31.1±4.5 33.9±4.4 −3.092 0.003
Prealbumin (g/L) 0.3±0.1 0.4±0.1 −2.706 0.009
Creatinine (μmol/L) 886.6±275.6 911.7±322.6 −0.392 0.696
GFR (mL/min/1.73m2) 5.0±1.5 5.1±2.2 −0.388 0.699
Hemoglobin (g/L) 98.8±17.2 107.4±21.6 −2.033 0.045
Ferritin (μg /L) 255.5±274.2 181.0±181.3 1.468 0.147
Transferrin (g/L) 1.72±0.49 1.83±0.46 −1.089 0.279
iPTH (pmol/L) 326.6±267. 6 291.3±209.0 0.712 0.478
Calcium (mmol/L) 2.2±0.3 2.2±0.2 −1.167 0.246
Phosphorus (mmol/L) 1.7±0.8 1.7±0.4 0.131 0.896
Sodium (mmol/L) 140.6±3.7 139.7±7.3 0.673 0.502
Potassium (mmol/L) 3.9±0.8 3.9±0.7 0.071 0.943
Cholesterol (mmol/L) 4.3±1.1 4.5±1.3 −0.547 0.586
Triglycerides (mmol/L) 1.7±0.9 2.3±1.4 −2.810 0.006
CRP (mg/L) 13.7±22.9 5.9±14.8 1.855 0.069
IL-6 (pg/mL) 13.5±16.1 7.1±3.9 2.166 0.038
TNF-α (ng/mL) 16.8±4.5 15.9±9.6 0.566 0.630
BNP (pg/mL) 768.0±1171.6 275.7±437.6 2.474 0.017
MIS 8.0±4.7 4.5±2.5 4.163 0.000
MIAS0 (n, %) 10 (26.3) 28 (50.9) 5.625 0.018
MIAS1 (n, %) 14 (36.8) 24 (43.6) 0.429 0.512
MIAS2 (n, %) 8 (21.1) 2 (3.6) 6.667 0.010
MIAS3 (n, %) 5 (13.2) 1 (1.8) 5.077 0.024
MIAS (1–3) (n, %) 28 (73.7) 27 (49.1) 5.979 0.014

Data are shown as the mean ± standard deviation, number (percentage); bold P values are statistically significant

BMI Body mass index, GFR Glomerular filtration rate, iPTH Intact parathyroid hormone, CRP C-reactive protein, IL-6 Interleukin-6, TNF-α Tumor necrosis factor-α, BNP B-type natriuretic peptide, MIS Malnutrition inflammation score, MIAS Malnutrition-inflammation-atherosclerosis syndrome;

※Group 2 and Group 1 are logograms for distinguishing scores above and below the Dialysis Effect Evaluation and Monitoring dimension mean score